Patents-Review.com
ClassID:

111317 ⎘

C12N2770/24132 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:
#1
20260053873
2026-02-26

COMBINATION THERAPY OF ONCOLYTIC VIRUS DRUGS FOR CANCER TREATMENT

 #2
20250154509
2025-05-15

ONCOLYTIC VIRUSES AND METHODS OF USE

 #3
20240342265
2024-10-17

E PROTEIN-MUTATED WEST NILE VIRUS USED AS LIVEATTENUATED VACCINE AND ONCOLYTIC DRUG FOR CANCER THERAPY

 #4
20240301364
2024-09-12

Compositions and Methods for Antigen Targeting to CD180

 #5
20240245738
2024-07-25

PHARMACEUTICAL KIT AND USES THEREOF

 #6
20230113073
2023-04-13

Compositions and methods for antigen targeting to CD180

 #7
20220213504
2022-07-07

Zika Virus Constructs and Therapeutic Compositions Thereof

 #8
20210322495
2021-10-21

ZIKA VIRUS TREATMENT OF CD24-POSITIVE TUMORS AND DISEASES ASSOCIATED WITH ABNORMAL T CELL ACTIVATION AND TREATING OR PREVENTING ZIKA VIRUS INFECTIONS

 #9
20210236568
2021-08-05

Method for treating cancer using dengue virus serotype 1 (DENV-1)

 #10
20210187086
2021-06-24

COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS

 #11
20210145907
2021-05-20

Zika virus strains for treatment of glioma

 #12
20200360497
2020-11-19

COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS

 #13
20200330581
2020-10-22

ONCOLYTIC CANCER IMMUNOTHERAPIES AND METHODS OF USE

 #14
20200216819
2020-07-09

Compositions and methods for antigen targeting to CD180

 #15
20200215133
2020-07-09

COMBINATION OF IMMUNO-ONCOLYTIC VIRUS DRUGS FOR ENHANCING SYSTEMIC IMMUNE RESPONSE AND APPLICATION THEREOF

 #16
20200078424
2020-03-12

COMPOSITIONS AND METHODS FOR THERAPY WITH DENGUE VIRUS

 #17
20190247479
2019-08-15

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #18
20190192593
2019-06-27

Method of inducing an oncolytic effect on tumor cells using Zika virus

 #19
20190144834
2019-05-16

Compositions and methods for antigen targeting to CD180

 #20
20190046622
2019-02-14

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #21
20190038685
2019-02-07

Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections

 #22
20180050098
2018-02-22

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #23
20170304422
2017-10-26

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #24
20170260274
2017-09-14

Construct for the delivery of a molecule into the cytoplasm of a cell

 #25
20170087233
2017-03-30

Compositions and methods for producing dendritic cells

 #26
20170000868
2017-01-05

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #27
20150238630
2015-08-27

Compositions and methods for antigen targeting to CD180

 #28
20080152633
2008-06-26

Flavivirus Replicon Constructs for Tumor Therapy